09:51 AM EST - Amorfix Life Sciences : announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients. Amorfix Life Sciences
shares T.AMF are trading up $0.025 at $0.50.
